title: Pharmaceutical approval update.
abstract: Dolutegravir (Tivicay) for HIV-1 infection; topiramate extended release (Trokendi XR) for epilepsy; and ferric carboxymaltose (Injectafer) for iron-deficiency anemia.
authors.forename: Marvin M
authors.initials: MM
authors.lastname: Goldenberg